Alembic Pharmaceuticals Limited (APLLTD.BO)
INR 850.0
(0.7%)
INR 850.0
(0.7%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 31.33 INR | 80.06% |
| 2022 | 17.40 INR | -34.34% |
| 2021 | 26.50 INR | -55.22% |
| 2020 | 59.18 INR | 34.59% |
| 2019 | 43.97 INR | 41.84% |
| 2018 | 31.00 INR | 41.62% |
| 2017 | 21.89 INR | 2.34% |
| 2016 | 21.39 INR | -43.99% |
| 2015 | 38.19 INR | 154.43% |
| 2014 | 15.01 INR | 20.18% |
| 2013 | 12.49 INR | 42.42% |
| 2012 | 8.77 INR | 27.1% |
| 2011 | 6.90 INR | 52.32% |
| 2010 | 4.53 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 6.85 INR | -24.59% |
| 2023 Q2 | 6.95 INR | 13.19% |
| 2023 FY | - INR | 80.06% |
| 2023 Q1 | 6.14 INR | -20.88% |
| 2023 Q3 | 9.18 INR | 32.09% |
| 2023 Q4 | 9.07 INR | -1.2% |
| 2022 Q2 | 6.78 INR | 302.39% |
| 2022 FY | - INR | -34.34% |
| 2022 Q3 | 6.20 INR | -8.55% |
| 2022 Q4 | 7.76 INR | 25.16% |
| 2022 Q1 | -3.35 INR | -720.37% |
| 2021 FY | - INR | -55.22% |
| 2021 Q2 | 8.34 INR | -0.36% |
| 2021 Q1 | 8.37 INR | -34.35% |
| 2021 Q3 | 8.74 INR | 4.8% |
| 2021 Q4 | 0.54 INR | -93.82% |
| 2020 FY | - INR | 34.59% |
| 2020 Q4 | 12.75 INR | -14.31% |
| 2020 Q3 | 14.88 INR | -13.69% |
| 2020 Q2 | 17.24 INR | 7.82% |
| 2020 Q1 | 15.99 INR | 0.0% |
| 2019 Q1 | 6.56 INR | 0.0% |
| 2019 FY | - INR | 41.84% |
| 2019 Q4 | - INR | -100.0% |
| 2019 Q2 | 13.06 INR | 99.09% |
| 2019 Q3 | 12.42 INR | -4.9% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q1 | 4.80 INR | -3.61% |
| 2018 Q2 | 10.61 INR | 121.04% |
| 2018 Q3 | 9.01 INR | -15.08% |
| 2018 FY | - INR | 41.62% |
| 2017 Q2 | 6.45 INR | 82.2% |
| 2017 FY | - INR | 2.34% |
| 2017 Q4 | 4.98 INR | -28.14% |
| 2017 Q3 | 6.93 INR | 7.44% |
| 2017 Q1 | 3.54 INR | -28.34% |
| 2016 Q1 | 5.50 INR | 14.11% |
| 2016 FY | - INR | -43.99% |
| 2016 Q3 | 4.59 INR | -27.83% |
| 2016 Q4 | 4.94 INR | 7.63% |
| 2016 Q2 | 6.36 INR | 15.64% |
| 2015 Q3 | 14.26 INR | -6.8% |
| 2015 Q1 | 3.72 INR | 0.0% |
| 2015 Q4 | 4.82 INR | -66.2% |
| 2015 FY | - INR | 154.43% |
| 2015 Q2 | 15.30 INR | 311.29% |
| 2014 Q4 | - INR | -100.0% |
| 2014 Q3 | 3.75 INR | -8.54% |
| 2014 Q2 | 4.10 INR | 19.53% |
| 2014 Q1 | 3.43 INR | 0.0% |
| 2014 FY | - INR | 20.18% |
| 2013 Q2 | 3.27 INR | 32.39% |
| 2013 Q1 | 2.47 INR | 0.0% |
| 2013 Q3 | 3.50 INR | 7.03% |
| 2013 FY | - INR | 42.42% |
| 2013 Q4 | - INR | -100.0% |
| 2012 FY | - INR | 27.1% |
| 2012 Q3 | 2.56 INR | 13.78% |
| 2012 Q4 | - INR | -100.0% |
| 2012 Q1 | 1.64 INR | 0.0% |
| 2012 Q2 | 2.25 INR | 37.2% |
| 2011 FY | - INR | 52.32% |
| 2010 FY | - INR | 0.0% |